Fluproquazone: Difference between revisions

Fluproquazone
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Latest revision as of 11:59, 15 February 2025

A non-steroidal anti-inflammatory drug

Fluproquazone is a non-steroidal anti-inflammatory drug (NSAID) that was developed for the treatment of pain and inflammation. It is part of the quinazolinone class of compounds and has been studied for its analgesic and anti-inflammatory properties.

Chemical Structure[edit]

Fluproquazone is characterized by its quinazolinone core structure, which is a bicyclic compound consisting of a benzene ring fused to a pyrimidine ring. This structure is common among several pharmaceutical agents with anti-inflammatory activity.

Mechanism of Action[edit]

Fluproquazone, like other NSAIDs, works by inhibiting the activity of cyclooxygenase (COX) enzymes. These enzymes are responsible for the conversion of arachidonic acid into prostaglandins, which are mediators of inflammation and pain. By reducing the production of prostaglandins, fluproquazone helps to alleviate symptoms associated with inflammatory conditions.

Pharmacokinetics[edit]

The pharmacokinetic profile of fluproquazone includes its absorption, distribution, metabolism, and excretion. After oral administration, fluproquazone is absorbed into the bloodstream and distributed throughout the body. It undergoes hepatic metabolism and is primarily excreted via the kidneys.

Clinical Use[edit]

Fluproquazone has been used in the management of various conditions associated with pain and inflammation, such as arthritis and musculoskeletal disorders. Its efficacy in reducing pain and improving function in these conditions has been evaluated in clinical trials.

Side Effects[edit]

As with other NSAIDs, fluproquazone may cause side effects, including gastrointestinal disturbances, such as gastritis and peptic ulcer disease, as well as renal and cardiovascular effects. Patients are advised to use this medication under medical supervision, especially if they have pre-existing conditions that may be exacerbated by NSAID use.

Related pages[edit]

@@ Line 1: / Line 1: @@
-'''Fluproquazone''' is a non-steroidal anti-inflammatory drug (NSAID) that was used in the past for the treatment of various inflammatory conditions, such as arthritis and dysmenorrhea. Like other NSAIDs, fluproquazone works by inhibiting the enzyme cyclooxygenase (COX), which is involved in the synthesis of prostaglandins, substances that play a key role in inflammation and pain. However, due to safety concerns, including potential adverse effects on the liver and the gastrointestinal tract, its use has been discontinued in many countries.
+{{Short description|A non-steroidal anti-inflammatory drug}}
+{{Drugbox
+| image = Fluproquazone.svg
+| image_size = 200px
+| image_alt = Chemical structure of Fluproquazone
+}}
-==Mechanism of Action==
+'''Fluproquazone''' is a [[non-steroidal anti-inflammatory drug]] (NSAID) that was developed for the treatment of pain and inflammation. It is part of the [[quinazolinone]] class of compounds and has been studied for its analgesic and anti-inflammatory properties.
-Fluproquazone inhibits the cyclooxygenase (COX) enzyme, which is responsible for the conversion of arachidonic acid to prostaglandin H2, a precursor of other prostaglandins. Prostaglandins are involved in various physiological processes, including inflammation, pain perception, and the regulation of body temperature. By inhibiting COX, fluproquazone reduces the production of prostaglandins, thereby alleviating inflammation and pain.
-==Indications==
+==Chemical Structure==
-Fluproquazone was primarily indicated for the treatment of:
+[[File:Fluproquazone.svg|thumb|right|Chemical structure of Fluproquazone]]
-* [[Rheumatoid arthritis]]
+Fluproquazone is characterized by its quinazolinone core structure, which is a bicyclic compound consisting of a benzene ring fused to a pyrimidine ring. This structure is common among several pharmaceutical agents with anti-inflammatory activity.
-* [[Osteoarthritis]]
-* [[Dysmenorrhea]]
-* Other conditions characterized by pain and inflammation
-==Adverse Effects==
+==Mechanism of Action==
-The use of fluproquazone, like other NSAIDs, is associated with a range of adverse effects, including:
+Fluproquazone, like other NSAIDs, works by inhibiting the activity of [[cyclooxygenase]] (COX) enzymes. These enzymes are responsible for the conversion of [[arachidonic acid]] into [[prostaglandins]], which are mediators of inflammation and pain. By reducing the production of prostaglandins, fluproquazone helps to alleviate symptoms associated with inflammatory conditions.
-* Gastrointestinal issues such as [[gastritis]], [[peptic ulcer]] disease, and gastrointestinal bleeding
-* Hepatotoxicity, including elevated liver enzymes and, in severe cases, liver failure
-* Renal impairment, including changes in renal function and, in rare cases, renal failure
-* Cardiovascular risks, such as hypertension and increased risk of myocardial infarction and stroke
-Due to these potential adverse effects, the use of fluproquazone has been limited, and it has been withdrawn from the market in several countries.
+==Pharmacokinetics==
+The pharmacokinetic profile of fluproquazone includes its absorption, distribution, metabolism, and excretion. After oral administration, fluproquazone is absorbed into the bloodstream and distributed throughout the body. It undergoes hepatic metabolism and is primarily excreted via the kidneys.
-==Pharmacokinetics==
+==Clinical Use==
-The pharmacokinetic properties of fluproquazone, including its absorption, distribution, metabolism, and excretion, were factors in its clinical use. Fluproquazone is metabolized in the liver and excreted primarily through the kidneys. The drug's half-life and bioavailability were considerations in determining dosing regimens.
+Fluproquazone has been used in the management of various conditions associated with pain and inflammation, such as [[arthritis]] and [[musculoskeletal disorders]]. Its efficacy in reducing pain and improving function in these conditions has been evaluated in clinical trials.
-==Regulatory Status==
+==Side Effects==
-The safety concerns associated with fluproquazone, particularly its hepatotoxicity and gastrointestinal side effects, led to a reevaluation of its risk-benefit profile. As a result, it has been withdrawn from the market in various countries, and its use is no longer recommended.
+As with other NSAIDs, fluproquazone may cause side effects, including gastrointestinal disturbances, such as [[gastritis]] and [[peptic ulcer disease]], as well as renal and cardiovascular effects. Patients are advised to use this medication under medical supervision, especially if they have pre-existing conditions that may be exacerbated by NSAID use.
-==Conclusion==
+==Related pages==
-While fluproquazone was once used to treat inflammation and pain associated with various conditions, its adverse effect profile, particularly the risk of hepatotoxicity and gastrointestinal complications, has led to its discontinuation. The development and availability of safer NSAIDs with more favorable risk-benefit ratios have rendered fluproquazone obsolete in current medical practice.
+* [[Non-steroidal anti-inflammatory drug]]
+* [[Cyclooxygenase]]
+* [[Prostaglandin]]
+* [[Quinazolinone]]
 [[Category:Non-steroidal anti-inflammatory drugs]]
-[[Category:Withdrawn drugs]]
+[[Category:Quinazolinones]]
-{{medicine-stub}}